Cannabis Drinks vs. Alcohol: Largest Real-World Study Reveals Big Substitution

The question of whether cannabis beverages can genuinely replace alcohol just moved from anecdote to data. A new real-world study — billed as the largest consumer dataset ever assembled on infused drinks — found that participants who started drinking THC beverages cut their weekly alcohol consumption roughly in half. For an industry that has spent two years pitching cannabis drinks as the sober-curious answer to happy hour, the cannabis beverage research arriving in 2026 is the closest thing yet to validation.

The study, run by the cannabis data company MoreBetter in partnership with the Network of Applied Pharmacognosy, tracked more than 5,000 participants across 20 brands and two cohorts. Cohort 2 findings were scheduled for release in a June 4 webinar, and the underlying work has also surfaced in peer-reviewed literature framing beverage substitution as a harm-reduction strategy. The headline numbers are striking, but the methodology and the caveats matter just as much.

What the Study Measured

Most cannabis-and-alcohol comparisons rely on surveys that ask people to recall their habits months after the fact — a method notoriously vulnerable to memory bias. The MoreBetter study took a different approach. Participants self-reported on a daily basis, logging their alcohol use, infused-beverage consumption, mood, and sleep outcomes over multiple weeks. That daily cadence, applied across thousands of people and 20 different brands, is what makes the dataset unusual.

Rather than testing a single product in a lab, the researchers observed how real consumers used commercially available cannabis beverages in their everyday settings — at home, at social gatherings, after work. The result is a picture of actual behavior rather than idealized conditions. MoreBetter presented aggregate data on participant beverage habits, multi-week consumption patterns, the settings where drinks were used, and consumer ratings of the overall experience.

This real-world design is both the study's strength and its limitation. It captures authentic behavior at scale, but it is observational: participants chose to enroll and chose to drink cannabis beverages, so the findings describe what happened among a self-selected group rather than proving cause and effect in a controlled trial.

The Substitution Numbers

The substitution signal was clear and consistent. Participants reported drinking fewer alcoholic beverages per week after starting cannabis drinks — an average of 3.35 weekly alcoholic drinks during the study, down from 7.02 before it began. That is close to a 52% reduction, and it tracks with the subjective experience participants described.

Roughly 71.7% of participants agreed or strongly agreed that they drank less alcohol while using infused beverages during the study. The shift was not just behavioral but attitudinal: 87.4% said infused beverages felt safer, or much safer, than alcohol for their health.

Those figures align with a broader cultural trend that has been building for several years, as a growing share of consumers — particularly younger adults — reach for low-dose THC drinks instead of beer or wine. What the study adds is scale and daily-tracking rigor to a phenomenon that had largely been measured through point-in-time polling.

Why Beverages, Specifically

There is a reason cannabis drinks, rather than edibles or flower, sit at the center of the alcohol-substitution conversation. A beverage maps neatly onto the social rituals alcohol already occupies. You can hold one at a party, sip it over the course of an evening, and pace yourself the way you would with a cocktail. The format fits the occasion in a way that a gummy or a joint does not.

Low-dose formulations reinforce that fit. Many infused beverages are dosed at 2 to 5 milligrams of THC per can — light enough to produce a mild, manageable lift rather than the intense, long-lasting effect of a high-dose edible. Advances in nano-emulsion technology have also shortened onset times, so the effect arrives in minutes rather than the hour-plus delay associated with traditional edibles. That faster, more predictable onset makes it easier for consumers to self-titrate, much as they would gauge a second glass of wine.

The health framing does real work here too. Alcohol carries well-documented risks, from liver disease to elevated cancer rates, and the "California sober" movement has popularized swapping it for cannabis. When 87.4% of study participants rated infused beverages as safer than alcohol, they were echoing a perception the wider market has been pricing in.

Reading the Findings Responsibly

It is worth stating plainly what this study does and does not establish. It documents that, among people who chose to use cannabis beverages and track their habits daily, alcohol consumption fell substantially. It does not prove that cannabis beverages are harmless, that the reductions persist long-term, or that the same effect would appear in the general population. Self-selection, the absence of a control group, and reliance on self-reported data all temper how far the results can be generalized.

Cannabis is not risk-free either. THC can impair coordination and judgment, carries dependence potential for some users, and interacts unpredictably with certain medications and mental-health conditions. Substituting one psychoactive substance for another is a personal calculation, not a blanket health endorsement. The most defensible reading of the data is that, for many adults already inclined to cut back on drinking, cannabis beverages appear to be a workable substitution tool — which is precisely how the peer-reviewed framing describes it: a potential harm-reduction strategy worth studying further.

What It Means for the Market and the Science

For beverage makers, the study is a marketing and a research milestone at once. It supplies the kind of large-sample, real-world evidence that brands have lacked when making substitution claims, and it gives investors a data point to weigh as the infused-drink category continues to expand. Expect the substitution narrative to feature heavily in product positioning through the rest of 2026.

For researchers, the more important contribution may be methodological. A 5,000-person, multi-brand, daily-tracked dataset establishes a template for studying cannabis consumption as it actually happens, outside the artificial constraints of a clinical lab. That kind of real-world evidence is increasingly valued across medicine, and applying it to cannabis — long starved of rigorous data because of federal restrictions — is a meaningful step.

The next questions are obvious. Do the reductions in drinking hold up over months and years? Are there subgroups for whom substitution backfires? And how do mood and sleep outcomes, which the study also tracked, fit into the picture? The June 4 release of Cohort 2 findings should begin to fill in some of those gaps.

Key Takeaways

• A MoreBetter study of 5,000+ participants across 20 brands is the largest real-world cannabis beverage dataset to date, with Cohort 2 findings released June 4, 2026.
• Participants averaged 3.35 weekly alcoholic drinks during the study, down from 7.02 before — roughly a 52% reduction.
• About 71.7% said they drank less alcohol while using infused beverages, and 87.4% rated the drinks as safer than alcohol for their health.
• Low doses (often 2–5 mg THC) and faster nano-emulsion onset make beverages fit social rituals alcohol traditionally occupies.
• The study is observational and self-selected, so it documents a strong substitution pattern rather than proving cause and effect.

This article discusses substance use as a health topic. Cannabis affects individuals differently and is not risk-free; anyone considering changes to alcohol or cannabis use should consult a healthcare professional.

Explore cannabis news, find dispensaries, and join the community at Budpedia.